» Articles » PMID: 6117682

HLA Restricted Virus-specific Cytotoxic T-lymphocyte Responses to Live and Inactivated Influenza Vaccines

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 1981 Oct 24
PMID 6117682
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

36 young adult volunteers were given either virus, or inactivated surface-antigen influenza vaccine, containing influenza A (H1N1) antigen. Their peripheral-blood lymphocytes were analysed to determine whether cytotoxic T lymphocytes (CTL) were induced by these vaccines. All three vaccines induced HLA-restricted T-lymphocyte responses specific for influenza A virus. This CTL response was found in 28 of 30 volunteers who showed antibody responses and in 3 of 6 who did not develop antibodies. Virus infected target cells showing certain HLA antigens (A1, A9, and B8) were less susceptible to lysis by HLA-matched cytotoxic T effector cells than target cells which matched effectors at other HLA loci.

Citing Articles

No Effect of Acute Eccentric Resistance Exercise on Immune Responses to Influenza Vaccination in Older Adults: A Randomized Control Trial.

Elzayat M, Markofski M, Simpson R, Laughlin M, Lavoy E Front Physiol. 2021; 12:713183.

PMID: 34456752 PMC: 8388854. DOI: 10.3389/fphys.2021.713183.


Atypical antibody responses to influenza.

Hermans D, Webby R, Wong S J Thorac Dis. 2018; 10(Suppl 19):S2238-S2247.

PMID: 30116603 PMC: 6072921. DOI: 10.21037/jtd.2017.12.122.


Connecting within-host dynamics to the rate of viral molecular evolution.

Peck K, Chan C, Tanaka M Virus Evol. 2016; 1(1):vev013.

PMID: 27774285 PMC: 5014490. DOI: 10.1093/ve/vev013.


Avian Influenza Viruses, Inflammation, and CD8(+) T Cell Immunity.

Wang Z, Loh L, Kedzierski L, Kedzierska K Front Immunol. 2016; 7:60.

PMID: 26973644 PMC: 4771736. DOI: 10.3389/fimmu.2016.00060.


Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine.

Mbawuike I, Atmar R, Patel S, Corry D, Winokur P, Brady R Vaccine. 2015; 34(4):547-554.

PMID: 26657997 PMC: 4713282. DOI: 10.1016/j.vaccine.2015.11.055.